Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,636 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $536.71 | 7 | $0 (2020) |
| GlaxoSmithKline, LLC. | $389.79 | 12 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $222.03 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.23 | 5 | $0 (2019) |
| SANOFI PASTEUR INC. | $94.99 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $63.67 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $26.95 | 2 | $0 (2018) |
| PFIZER INC. | $23.52 | 2 | $0 (2018) |
| Amgen Inc. | $20.44 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $19.96 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97.31 | 1 | AstraZeneca Pharmaceuticals LP ($97.31) |
| 2020 | $259.21 | 6 | Novo Nordisk Inc ($125.00) |
| 2019 | $416.52 | 8 | Novo Nordisk Inc ($279.75) |
| 2018 | $436.24 | 15 | GlaxoSmithKline, LLC. ($150.94) |
| 2017 | $427.20 | 14 | GlaxoSmithKline, LLC. ($190.44) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: Respiratory | ||||||
| 03/10/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 03/04/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 01/22/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), FLULAVAL QUADRIVALENT | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: VACCINES | ||||||
| 01/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $68.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 09/24/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 09/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 08/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: DIABETES | ||||||
| 06/04/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 04/24/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $94.99 | General |
| Category: VACCINES | ||||||
| 03/11/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Respiratory | ||||||
| 01/15/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 10/11/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/26/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 08/28/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: DIABETES | ||||||
| 08/14/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Respiratory | ||||||
| 07/10/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Diabetes | ||||||
| 06/07/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug), ONZETRA Xsail | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/22/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 242 | 325 | $42,468 | $19,686 |
| 2022 | 10 | 281 | 354 | $42,485 | $19,937 |
| 2021 | 11 | 352 | 463 | $56,881 | $27,144 |
| 2020 | 11 | 341 | 418 | $48,867 | $19,648 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 121 | $25,410 | $10,817 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $7,595 | $3,920 | 51.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 28 | 29 | $3,625 | $1,607 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,080 | $836.30 | 40.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 26 | 26 | $728.00 | $654.16 | 89.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $580.00 | $528.09 | 91.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $560.00 | $509.88 | 91.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $490.00 | $422.10 | 86.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 14 | $980.00 | $305.79 | 31.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 20 | 20 | $420.00 | $85.80 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 116 | $24,360 | $10,248 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $8,820 | $4,649 | 52.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 26 | 26 | $3,250 | $1,469 | 45.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 30 | 30 | $840.00 | $773.54 | 92.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 35 | 35 | $700.00 | $651.30 | 93.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 35 | 35 | $700.00 | $639.26 | 91.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $630.00 | $525.78 | 83.5% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 14 | $1,330 | $472.74 | 35.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 19 | 19 | $1,330 | $400.71 | 30.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 25 | 25 | $525.00 | $107.86 | 20.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 145 | $30,450 | $13,509 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $9,800 | $5,275 | 53.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 32 | 32 | $4,000 | $1,925 | 48.1% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Office | 2021 | 15 | 26 | $3,250 | $1,538 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 22 | $3,520 | $1,312 | 37.3% |
About Dr. Maureen Lee, D.O
Dr. Maureen Lee, D.O is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275635781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maureen Lee, D.O has received a total of $1,636 in payments from pharmaceutical and medical device companies, with $97.31 received in 2024. These payments were reported across 44 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,636).
As a Medicare-enrolled provider, Lee has provided services to 1,216 Medicare beneficiaries, totaling 1,560 services with total Medicare billing of $86,415. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Biddeford, ME
- Active Since 09/04/2006
- Last Updated 08/22/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275635781
Products in Payments
- Ozempic (Drug) $396.24
- SHINGRIX (Biological) $157.71
- Tresiba (Drug) $140.47
- INCRUSE (Drug) $124.99
- AIRSUPRA (Drug) $97.31
- FLUZONE HIGH-DOSE (Drug) $94.99
- FARXIGA (Drug) $68.68
- Myrbetriq (Drug) $63.67
- SYMBICORT (Drug) $41.57
- ANORO (Drug) $35.16
- SPIRIVA RESPIMAT (Drug) $34.16
- BREO (Drug) $29.36
- TRELEGY ELLIPTA (Drug) $29.30
- TRADJENTA (Drug) $28.27
- CHANTIX (Drug) $23.52
- Prolia (Biological) $20.44
- TOUJEO (Drug) $19.96
- NUEDEXTA (Drug) $19.67
- XARELTO (Drug) $19.60
- Dymista (Drug) $18.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Dr. Peter Rubin, M.d, M.D
Internal Medicine — Payments: $31,481
Yasmin Mahal, Do, DO
Internal Medicine — Payments: $2,642
Steven Cutone, D.o, D.O
Internal Medicine — Payments: $2,606
Jennifer Cutone, M.d, M.D
Internal Medicine — Payments: $2,262
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712